|
1
|
Yin W, Wang J, Jiang L and James Kang Y:
Cancer and stem cells. Exp Biol Med (Maywood). 246:1791–1801. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rowbotham SP, Goruganthu MUL, Arasada RR,
Wang WZ, Carbone DP and Kim CF: Lung cancer stem cells and their
clinical implications. Cold Spring Harb Perspect Med.
12:a0412702022.PubMed/NCBI
|
|
3
|
Walcher L, Kistenmacher AK, Suo H, Kitte
R, Dluczek S, Strauß A, Blaudszun AR, Yevsa T, Fricke S and
Kossatz-Boehlert U: Cancer stem cells-origins and biomarkers:
Perspectives for targeted personalized therapies. Front Immunol.
11:12802020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang D, Tang DG and Rycaj K: Cancer stem
cells: Regulation programs, immunological properties and
immunotherapy. Semin Cancer Biol. 52:94–106. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zimmermannova O, Ferreira AG, Ascic E,
Velasco Santiago M, Kurochkin I, Hansen M, Met Ö, Caiado I, Shapiro
IE, Michaux J, et al: Restoring tumor immunogenicity with dendritic
cell reprogramming. Sci Immunol. 8:eadd48172023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bayik D and Lathia JD: Cancer stem
cell-immune cell crosstalk in tumour progression. Nat Rev Cancer.
21:526–536. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Doherty MR, Smigiel JM, Junk DJ and
Jackson MW: Cancer stem cell plasticity drives therapeutic
resistance. Cancers (Basel). 8:82016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Y, Wang J, Chen J, Wu S, Zeng X, Xiong
Q, Guo Y, Sun J, Song F, Xu J, et al: Upregulation of miR-520c-3p
via hepatitis B virus drives hepatocellular migration and invasion
by the PTEN/AKT/NF-κB axis. Mol Ther Nucleic Acids. 29:47–63. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Todaro M, Alea MP, Di Stefano AB,
Cammareri P, Vermeulen L, Iovino F, Tripodo C, Russo A, Gulotta G,
Medema JP and Stassi G: Colon cancer stem cells dictate tumor
growth and resist cell death by production of interleukin-4. Cell
Stem Cell. 1:389–402. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dean M: ABC transporters, drug resistance,
and cancer stem cells. J Mammary Gland Biol Neoplasia. 14:3–9.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang T, Song X, Xu D, Tiek D, Goenka A,
Wu B, Sastry N, Hu B and Cheng SY: Stem cell programs in cancer
initiation, progression, and therapy resistance. Theranostics.
10:8721–8743. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shekhani MT, Jayanthy AS, Maddodi N and
Setaluri V: Cancer stem cells and tumor transdifferentiation:
Implications for novel therapeutic strategies. Am J Stem Cells.
2:52–61. 2013.PubMed/NCBI
|
|
13
|
Garvalov BK and Acker T: Cancer stem
cells: A new framework for the design of tumor therapies. J Mol Med
(Berl). 89:95–107. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Morazán-Fernández D, Mora J and
Molina-Mora JA: In silico pipeline to identify tumor-specific
antigens for cancer immunotherapy using exome sequencing data.
Phenomics. 3:130–137. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morrison BJ, Steel JC and Morris JC:
Sphere culture of murine lung cancer cell lines are enriched with
cancer initiating cells. PLoS One. 7:e497522012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pardoll D: Does the immune system see
tumors as foreign or self? Annu Rev Immunol. 21:807–839. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hinterleitner C, Strähle J, Malenke E,
Hinterleitner M, Henning M, Seehawer M, Bilich T, Heitmann J, Lutz
M, Mattern S, et al: Platelet PD-L1 reflects collective
intratumoral PD-L1 expression and predicts immunotherapy response
in non-small cell lung cancer. Nat Commun. 12:70052021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gilboa E: DC-based cancer vaccines. J Clin
Invest. 117:1195–1203. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jego G, Pascual V, Palucka AK and
Banchereau J: Dendritic cells control B cell growth and
differentiation. Curr Dir Autoimmun. 8:124–139. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qi H, Egen JG, Huang AYC and Germain RN:
Extrafollicular activation of lymph node B cells by antigen-bearing
dendritic cells. Science. 312:1672–1676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rojas-Sepúlveda D, Tittarelli A, Gleisner
MA, Ávalos I, Pereda C, Gallegos I, González FE, López MN, Butte
JM, Roa JC, et al: Tumor lysate-based vaccines: On the road to
immunotherapy for gallbladder cancer. Cancer Immunol Immunother.
67:1897–1910. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ragde H, Cavanagh WA and Tjoa BA:
Dendritic cell based vaccines: Progress in immunotherapy studies
for prostate cancer. J Urol. 172:2532–2538. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ni L: Advances in human dendritic
cell-based immunotherapy against gastrointestinal cancer. Front
Immunol. 13:8871892022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dwivedi R, Pandey R, Chandra S and
Mehrotra D: Dendritic cell-based immunotherapy: a potential player
in oral cancer therapeutics. Immunotherapy. 15:457–469. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang J, Shangguan J, Eresen A, Li Y, Wang
J and Zhang Z: Dendritic cells in pancreatic cancer immunotherapy:
Vaccines and combination immunotherapies. Pathol Res Pract.
215:1526912019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qian D, Li J, Huang M, Cui Q, Liu X and
Sun K: Dendritic cell vaccines in breast cancer: Immune modulation
and immunotherapy. Biomed Pharmacother. 162:1146852023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gu JH and Li G: Dendritic cell-based
immunotherapy for malignant glioma. Neurosci Bull. 24:39–44. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang X, He T, Li Y, Chen L, Liu H, Wu Y
and Guo H: Dendritic cell vaccines in ovarian cancer. Front
Immunol. 11:6137732021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Perrigue PM, Rakoczy M, Pawlicka KP,
Belter A, Giel-Pietraszuk M, Naskręt-Barciszewska M, Barciszewski J
and Figlerowicz M: Cancer stem cell-inducing media activates
senescence reprogramming in fibroblasts. Cancers (Basel).
12:17452020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chometon TQ, Siqueira MDS, Sant Anna JC,
Almeida MR, Gandini M, Martins de Almeida Nogueira AC and Antas
PRZ: A protocol for rapid monocyte isolation and generation of
singular human monocyte-derived dendritic cells. PLoS One.
15:e02311322020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kokkinopoulos D, Perez S, Sotiriadou R,
Stinios J and Papamichail M: The use of nylon wool for the
isolation of T lymphocyte subpopulations. J Immunol Methods.
154:1–6. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Luo Y, Chen J, Liu M, Chen S, Su X, Su J,
Zhao C, Han Z, Shi M, Ma X and Huang H: Twist1 promotes dendritic
cell-mediated antitumor immunity. Exp Cell Res. 392:1120032020.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Han F, Guo S, Huang C, Cui L, Zhao Y, Ma
J, Zhu M, Chen Z, Wang M, Shen B and Zhu W: Gastric cancer
mesenchymal stem cells inhibit natural killer cell function by
up-regulating FBP1. Cent Eur J Immunol. 46:427–437. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
In H, Park JS, Shin HS, Ryu SH, Sohn M,
Choi W, Park S, Hwang S, Park J, Che L, et al: Identification of
dendritic cell precursor from the CD11c+ cells
expressing high levels of MHC class II molecules in the culture of
bone marrow with FLT3 ligand. Front Immunol. 14:11799812023.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wei W, Mu S, Han Y, Chen Y, Kuang Z, Wu X,
Luo Y, Tong C, Zhang Y, Yang Y and Song Z: Gpr174 knockout
alleviates DSS-induced colitis via regulating the immune function
of dendritic cells. Front Immunol. 13:8412542022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang Y, Xiang Y, Xin VW, Wang XW, Peng XC,
Liu XQ, Wang D, Li N, Cheng JT, Lyv YN, et al: Dendritic cell
biology and its role in tumor immunotherapy. J Hematol Oncol.
13:1072020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hanna JM and Onaitis MW: Cell of origin of
lung cancer. J Carcinog. 12:62013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Saxena M, Balan S, Roudko V and Bhardwaj
N: Towards superior dendritic-cell vaccines for cancer therapy. Nat
Biomed Eng. 2:341–346. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bol KF, Schreibelt G, Gerritsen WR, de
Vries IJ and Figdor CG: Dendritic cell-based immunotherapy: State
of the art and beyond. Clin Cancer Res. 22:1897–1906. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kaczmarek M, Poznańska J, Fechner F,
Michalska N, Paszkowska S, Napierała A and Mackiewicz A: Cancer
vaccine therapeutics: limitations and effectiveness-a literature
review. Cells. 12:21592023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fu C, Zhou L, Mi QS and Jiang A: DC-based
vaccines for cancer immunotherapy. Vaccines (Basel). 8:7062020.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hato L, Vizcay A, Eguren I, Pérez-Gracia
JL, Rodríguez J, Gállego Pérez-Larraya J, Sarobe P, Inogés S, Díaz
de Cerio AL and Santisteban M: Dendritic cells in cancer immunology
and immunotherapy. Cancers (Basel). 16:9812024. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Perez CR and De Palma M: Engineering
dendritic cell vaccines to improve cancer immunotherapy. Nat
Commun. 10:54082019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mastelic-Gavillet B, Balint K, Boudousquie
C, Gannon PO and Kandalaft LE: Personalized dendritic cell
vaccines-recent breakthroughs and encouraging clinical results.
Front Immunol. 10:7662019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Abraham RS and Mitchell DA: Gene-modified
dendritic cell vaccines for cancer. Cytotherapy. 18:1446–1455.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Masoumi J, Ghorbaninezhad F, Saeedi H,
Safaei S, Khaze Shahgoli V, Ghaffari Jolfayi A, Naseri B,
Baghbanzadeh A, Baghbani E, Mokhtarzadeh A, et al: siRNA-mediated
B7H7 knockdown in gastric cancer lysate-loaded dendritic cells
amplifies expansion and cytokine secretion of autologous T cells.
Biomedicines. 11:32122023. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen L, Zhang D, Chen Y, Zhu H, Liu Z, Yu
Z and Xie J: ORC6 acts as an effective prognostic predictor for
non-small cell lung cancer and is closely associated with tumor
progression. Oncol Lett. 27:962024. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Campillo-Davo D, Versteven M, Roex G, De
Reu H, Heijden SV, Anguille S, Berneman ZN, Tendeloo VFIV and Lion
E: Rapid assessment of functional avidity of tumor-specific T cell
receptors using an antigen-presenting tumor cell line
electroporated with full-length tumor antigen mRNA. Cancers
(Basel). 12:2562020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Constantino J, Gomes C, Falcão A, Neves BM
and Cruz MT: Dendritic cell-based immunotherapy: A basic review and
recent advances. Immunol Res. 65:798–810. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Elster JD, Krishnadas DK and Lucas KG:
Dendritic cell vaccines: A review of recent developments and their
potential pediatric application. Hum Vaccin Immunother.
12:2232–2239. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Antonios JP, Soto H, Everson RG, Orpilla
J, Moughon D, Shin N, Sedighim S, Yong WH, Li G, Cloughesy TF, et
al: PD-1 blockade enhances the vaccination-induced immune response
in glioma. JCI Insight. 1:e870592016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ge Y, Xi H, Ju S and Zhang X: Blockade of
PD-1/PD-L1 immune checkpoint during DC vaccination induces potent
protective immunity against breast cancer in hu-SCID mice. Cancer
Lett. 336:253–259. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zitvogel L, Apetoh L, Ghiringhelli F,
André F, Tesniere A and Kroemer G: The anticancer immune response:
Indispensable for therapeutic success? J Clin Invest.
118:1991–2001. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wheeler CJ, Das A, Liu G, Yu JS and Black
KL: Clinical responsiveness of glioblastoma multiforme to
chemotherapy after vaccination. Clin Cancer Res. 10:5316–5326.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wang S, Song Y, Shi Q, Qiao G, Zhao Y,
Zhou L, Zhao J, Jiang N and Huang H: Safety of dendritic cell and
cytokine-induced killer (DC-CIK) cell-based immunotherapy in
patients with solid tumor: A retrospective study in China. Am J
Cancer Res. 13:4767–4782. 2023.PubMed/NCBI
|
|
56
|
Wang S, Wang X, Zhou X, Lyerly HK, Morse
MA and Ren J: DC-CIK as a widely applicable cancer immunotherapy.
Expert Opin Biol Ther. 20:601–607. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Bhattacharyya T, Purushothaman K,
Puthiyottil SS, Bhattacharjee A and Muttah G: Immunological
interactions in radiotherapy-opening a new window of opportunity.
Ann Transl Med. 4:512016.PubMed/NCBI
|
|
58
|
Ge C, Yang X, Xin J, Gong X, Wang X and
Kong L: Recent advances in antitumor dendritic cell vaccines.
Cancer Biother Radiopharm. 38:450–457. 2023.PubMed/NCBI
|
